03 Apr 2018 --- Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health, Ltd., New Zealand, to supply China and Asia-Pacific with astaxanthin and other algae-based products. The Asia-Pacific market for such products is valued at several hundred million dollars, and forecast to experience rapid growth. Israeli-based Algatech specializes in the commercial cultivation of microalgae and manufactures natural astaxanthin, marketed in 35 countries under its AstaPure brand.